Pharmaceuticals

From pimples to peptides: How Gen Z turned the dermatologist into a beauty guru The Times of India01:05
Deadline diet India's young workforce faces cardiac scare The Times of India18:55
Not a second time: FDA’s Office of Prescription Drug Promotion issues a Warning Letter to a company for unlawful… JD Supra06:42
Discovery of key protein reveals why exercise strengthens muscles and bones News-Medical.Net20:03
FDA approves new HIV prevention drug WLBT00:36
Korean biotech firm bought by Parataxis for Bitcoin treasury use Cointelegraph15:36
NICE recommends spevigo for rare and severe psoriasis flares Pharmafile14:58

Latest News

In the last 5 minutes

Revolutionary HIV preventive treatment approved in the US Bursa.ro22:03

In the last 2 hours

Eli Lilly (NYSE:LLY) Advances Orforglipron GLP-1 Therapy To Phase 3 With Positive Results Simply Wall St20:46

Novo’s CagriSema Shot Tied to Greater Weight Loss at Lower Doses Bloomberg Law20:30

In the last 4 hours

Novo Nordisk: Ignored GLP-1 Leader Is Now A Deep Value Play Seeking Alpha18:36

Pfizer: An Offensive Play For A Bear Market Seeking Alpha18:36

In the last 6 hours

Former NBA Star Dishes On Diddy Parties, Johnson & Johnson Baby Oil Sports Illustrated17:18

StockWatch: CGT Stocks Fall on FDA Therapeutic Products Upheaval Genetic Engineering and Biotechnology News17:10

In the last 8 hours

ADA 2025: Breaking Barriers in Glucagon Prescription Pharmacy Times16:01

Novo Nordisk weight-loss drug trial show mostly mild side effects Yahoo! UK & Ireland15:32

ADA 2025: Bridging Gaps in Diabetes Management and Patient Care Pharmacy Times15:10

AI in business, data analytics, wetland conservation debut as Ug courses The Times of India14:15

Earlier today

Data on Novo Nordisk experimental weight-loss drug show mostly mild side effects Yahoo! US14:05

Novo Nordisk’s amylin obesity drug keeps performing like Zepbound STAT14:03

A new HIV drug promises 99.9% protection. But it's making Indian health activists wary; Why? The Times of India13:03

Long-Term Durability and Cost-Effectiveness of Adalimumab Biosimilars in Pediatric IBD Center for Biosimilars12:46

HIV prevention drug lenacapavir gets FDA nod, nearly 100 per cent effective says experts The Week (India)12:21

Amazon launches home diagnostic services in 6 cities through app The Times of India12:11

This drug may lower stroke risk in type 2 diabetes Knowridge Science Report12:08

Opinion: Jim Martin: Let’s ban those annoying and dangerous pharmaceutical drug commercials Boulder Daily Camera, Colorado12:01

[BIO USA 2025] SK biopharmaceuticals CEO highlights physician engagement, epilepsy sales in US Korea Biomedical Review09:21

Naip To Host 28th Scientific Conference As Pharma Sector Eyes 70% Local Drug Production Leadership, Nigeria09:17

SK Biopharmaceuticals CEO highlights resilience, open innovation amid global shifts The Korea Herald09:07

'Game changer' diabetes pill a step closer after trials The Canberra Times07:49

Eli Lilly Says Its Anti-Obesity Pill Orforglipron Shows Promising Results Outlook Business06:33

ADA 2025: Semaglutide Shows Promise in Improving Mobility for Patients With Diabetes and Peripheral Arterial Disease Pharmacy Times05:19

Biocon Full Year 2025 Earnings: Beats Expectations Simply Wall St04:29

How animal testing in US could be transformed under Trump The News Tribune, Washington04:06

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts The Motley Fool01:48

From pimples to peptides: How Gen Z turned the dermatologist into a beauty guru The Times of India01:05

Sanofi (ENXTPA:SAN) Gains FDA Approval For Dupixent To Address Rare Skin Disease Simply Wall St00:25

Yesterday

KFF Health News' 'What the Health?': GOP Tries To Cut Billions in Health Benefits Kaiser Health News22:55 21-Jun-25

Novel Oral GLP-1 Agent Cuts A1c, Weight in Early Diabetes Medpage Today22:40 21-Jun-25

Making AI Safe for Mental Health Use Psychology Today21:41 21-Jun-25

Entire Genus of Jumping Spiders Found Hidden in New Zealand ScienceAlert20:08 21-Jun-25

Deadline diet India's young workforce faces cardiac scare The Times of India18:55 21-Jun-25

Eli Lilly says its anti-obesity pill matches Ozempic The Times of India18:48 21-Jun-25

An Opportunity Or a Threat: How to Have Safer, Less Expensive Drugs The Independent Institute (Weblog)17:53 21-Jun-25

Gas Stations Are Selling a Sleazy Drug That Gives You Seizures Futurism16:38 21-Jun-25

Sona Nanotech signs Chile trial partner for targeted hyperthermia therapy trial - ICYMI Proactive Investors (US)16:17 21-Jun-25

Why this author wrote about creative women as they aged: ‘They made much of less’ Los Angeles Times16:06 21-Jun-25

Kraft Heinz Is Eliminating Food Dyes By 2027 Prevention.com15:26 21-Jun-25

ADA 2025: Technology, Treatment, and Transformation in Diabetes Management Pharmacy Times15:16 21-Jun-25

Parataxis May Transform Bridge Biotherapeutics Into KOSDAQ-Listed Bitcoin Treasury Platform Coinotag14:48 21-Jun-25

Lilly expects orforglipron obesity results in third quarter Yahoo! UK & Ireland14:16 21-Jun-25

Emcure Pharma to acquire remaining 20.42% stake in Zuventus Healthcare for Rs 724.9 cr The Times of India14:14 21-Jun-25

BMJ investigation raises new concerns over ticagrelor approval trials News-Medical.Net14:10 21-Jun-25

Eli Lilly’s Obesity Pill Appears to Work as Well as Injected GLP-1s WIRED14:10 21-Jun-25

PCN Shuts 67 Pharmaceutical Stores In Lagos Naija News14:09 21-Jun-25

Lilly’s Experimental Obesity Pill Holds Up to Scrutiny in Trial Bloomberg Law14:00 21-Jun-25

US FDA approves twice-a-year HIV shot that could end daily pills The Financial Express13:39 21-Jun-25

STInt: An integrated dataset covering science, technology and industry information in the pharmaceutical field Nature.com11:49 21-Jun-25

Popular cholesterol drug may pose kidney risks, study finds Knowridge Science Report11:23 21-Jun-25

Biocon Completes Raising Rs 4,500 Crore Via QIP Outlook Business10:23 21-Jun-25

Conflicting lab reports under scrutiny - Namal Karunaratne Sri Lanka Daily Mirror07:46 21-Jun-25

Not a Second Time: FDA’s Office of Prescription Drug Promotion Issues a Warning Letter to a Company for Unlawful… JD Supra06:42 21-Jun-25

DOJ Civil Division Announces 2025 Priorities: Promises “Aggressive” False Claims Act Enforcement of Civil Rights… JD Supra06:21 21-Jun-25

From Molecule to Market Treehill CEO Highlights Full Spectrum Diligence as Key to Biotech Funding BioSpectrum Asia05:31 21-Jun-25

Biocon raises Rs 4,500 crore via QIP The Business Standard05:19 21-Jun-25

Inquiry committee submits report on VS illegal trials to Ahmedabad municipal commissioner The Times of India05:11 21-Jun-25

Experimental new pill results in up to 24% weight loss Radio New Zealand03:07 21-Jun-25

Four Indian pharma stocks that may be hit by US pharma tariff threat Mint02:39 21-Jun-25

Econometer: Should the US ban drug advertising to consumers? Lexington Herald-Leader, Kentucky02:26 21-Jun-25

FDA approves new HIV prevention drug WLBT00:36 21-Jun-25

STAT Plus: Full data on Novo Nordisk’s new amylin drug raise dosing questions STAT00:34 21-Jun-25

STAT Plus: Off-the-shelf stem cell therapy for type 1 diabetes continues to show positive… STAT00:21 21-Jun-25

OPC 2025: Adapting Oncology Pharmacy to the Age of AI and Drug Shortages Pharmacy Times00:10 21-Jun-25

Lantheus Holdings (NasdaqGM:LNTH) Joins FIBRE Consortium To Transform Fibrotic Disease Treatment Simply Wall St00:00 21-Jun-25

Abbott Laboratories (NYSE:ABT) Enhances Diabetes Care And Partners With Abu Dhabi For Pharma Expansion Simply Wall St00:00 21-Jun-25

In the last 7 days

STAT Plus: GLP-1 reduced migraine frequency by nearly half, in a pilot study STAT23:10 20-Jun-25

OPC 2025: Key Studies Shaping Lung Cancer Therapy From ASCO 2025 Pharmacy Times22:59 20-Jun-25

Asia Deal Watch: SunRock, Escugen Collaborate On CCR9-Targeted ADC Scrip Pharma Intelligence22:47 20-Jun-25

J&J’s Trispecific Antibody For Myeloma Offers Improved Safety, Potency Over Bispecifics Scrip Pharma Intelligence22:47 20-Jun-25

Biotech industry faces off: US vs. China Yahoo! UK & Ireland22:30 20-Jun-25

Top Research Reports for Meta Platforms, Palantir & Abbott Zacks22:29 20-Jun-25

Health Care Week in Review | Senate Finance Committee Releases Budget Reconciliation Text; SCOTUS Upholds TN Ban on... JD Supra22:11 20-Jun-25

'Gas station heroin' is technically illegal and widely available. Here are the facts Japan Today22:02 20-Jun-25

Q&A: Innovations in cannabinoid science and commerce Digital Journal21:55 20-Jun-25

Naip Pushes Digital Innovation As Nigeria Targets Pharma Independence Independent Nigeria21:45 20-Jun-25

Immunotherapy Takes the Lead in Advanced Cutaneous Malignancies Pharmacy Times21:27 20-Jun-25

Progress in NSCLC Relies on Representative Trial Participation Medpage Today21:14 20-Jun-25

Nice rejects Lilly‘s Kisunla and Eisai‘s Leqembi BioWorld20:51 20-Jun-25

Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says Yahoo! UK & Ireland20:48 20-Jun-25

FDA Offers Speedier Approvals to Select Drug Companies HumanProgress20:46 20-Jun-25

DOJ Civil Division Announces 2025 Priorities: Promises “Aggressive” False Claims Act Enforcement of Civil Rights… National Law Review20:43 20-Jun-25

Recent PTAB Developments for Regeneron’s Aflibercept Formulation Patent JD Supra20:40 20-Jun-25

Morrisville biotech hub, ‘built on spec,’ signs first tenant amid glut of space News & Observer, North Carolina20:29 20-Jun-25

Regeneron Files Another Complaint Against Amgen in Aflibercept BPCIA Litigation JD Supra20:10 20-Jun-25

A $1.3 Billion Reason to Buy Eli Lilly Stock Now Barchart20:07 20-Jun-25

The 5 Most Interesting Analyst Questions From Merck’s Q1 Earnings Call Barchart20:07 20-Jun-25

Discovery of key protein reveals why exercise strengthens muscles and bones News-Medical.Net20:03 20-Jun-25

Novel method could optimise beta-blocker synthesis European Pharmaceutical Review20:02 20-Jun-25

Rare Disease Therapies Gain Momentum With Regulatory Support and Continued Market Growth JD Supra19:59 20-Jun-25

STAT Plus: Pharmalittle: We’re reading about FDA forcing out top gene therapy regulator,… STAT19:59 20-Jun-25

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits Pharmacy Times19:56 20-Jun-25

Threat in the Medicine Cabinet: The FDA's Gamble on America's Drugs Medpage Today19:52 20-Jun-25

“Expect Graham To Make His Presence Felt”: Ohio State Buckeyes Wide Receiver Mylan Graham Could … Gridiron Heroics19:48 20-Jun-25

Tired of living with chronic pain? Learn ... Community Impact Newspaper19:35 20-Jun-25

FDA’s AI tool Elsa signals new era for regulatory review, says QuantHealth CEO Drug Discovery & Development19:31 20-Jun-25

KFF Health News' 'What the Health?': Supreme Court Upholds Bans on Gender-Affirming Care Kaiser Health News19:21 20-Jun-25

GLP-1 Drugs Can Be Used First for Weight Loss, Says American College of Cardiology Medpage Today19:12 20-Jun-25

Clinical Trials Financially Beneficial for Patients: Eric Lander, MD American Journal of Managed Care18:42 20-Jun-25

Will FDA’s New Review Process Sell Drug Approvals to the Highest Bidder? Pain News Network18:30 20-Jun-25

Inside the Synergy Between HOPA and OPC’s Evolving Educational Impact Pharmacy Times18:15 20-Jun-25

FDA Approves Tafasitamab for Follicular Lymphoma American Journal of Managed Care18:12 20-Jun-25

Humor in drug ads? Biogen, 21Grams make it work with gold-winning campaign at Cannes Pharma… FiercePharma18:07 20-Jun-25

Why Are MAHA Influencers So Obsessed With Parasites? Vanity Fair18:07 20-Jun-25

Queen Latifah’s Secret to Joy: ‘We 50-Year-Old Women Are on a Fun Ride!’ The Tribune, California18:06 20-Jun-25

FDA Approves Dupilumb for Treatment of Bullous Pemphigoid Pharmacy Times18:04 20-Jun-25

CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech Zacks18:04 20-Jun-25

STAT Plus: Disagreements over Duchenne therapy, management style may have led to ouster of key… STAT18:00 20-Jun-25

YuvaBio strikes obesity drug discovery deal with Northstrive Longevity Technology17:59 20-Jun-25

Stress at work? Doctors see rise in heart diseases among young executives The Times of India17:55 20-Jun-25

Biocon closes ₹4,500 crore QIP to boost innovation, expand global access The Business Standard17:47 20-Jun-25

Biocon raises Rs 4,500 crore through successful Qip The Economic Times17:38 20-Jun-25

Guide to Ozempic/Wegovy Vision Loss Lawsuits and Settlements JD Supra17:27 20-Jun-25

view more headlines

22 Jun 22:03

About our Pharmaceuticals news

NewsNow aims to be the world's most accurate and comprehensive pharmaceutical news aggregator, bringing you the latest headlines from the best pharma sites and other key national and regional news sources. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Pharmaceuticals

Latest News

About our Pharmaceuticals news

UK Top Stories

World Top Stories